Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL PHARMA Gains 6%; BSE HEALTHCARE Index Up 1.4%
Thu, 31 Oct 12:17

PIRAMAL PHARMA Gains 6%; BSE HEALTHCARE Index Up 1.4%Image source: Ivcandy/www.istockphoto.com

PIRAMAL PHARMA share price has zoomed 6% and is presently trading at Rs 267.4.

Meanwhile, the BSE HEALTHCARE index is at 43,698.7 (up 1.4%).

Among the top gainers in the BSE HEALTHCARE index today are Cipla (up 9.9%) and Jubilant Pharmova (up 4.3%).

SYNGENE INTERNATIONAL (down 1.8%) and Biocon (down 1.6%) are among the top losers today.

Over the last one year, PIRAMAL PHARMA has moved up from Rs 95.6 to Rs 267.4, registering a gain of Rs 171.8 (up 179.8%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,385.2 to 43,698.7, registering a gain of 59.6% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 209.8%), SUVEN PHARMACEUTICALS (up 127.8%) and Glenmark Pharma (up 124.0%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 79,517.5 (down 0.5%).

The top losers among the BSE Sensex today are Tech Mahindra (down 4.7%) and HCl Tech. (down 3.1%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,236.8 (down 0.4%). Tech Mahindra and HCl Tech. are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 64,112.7 to 79,517.5, registering a gain of 15,404.8 points (up 24.0%).

PIRAMAL PHARMA Financial Update...

PIRAMAL PHARMA net profit grew 137.8% YoY to Rs 53 million for the quarter ended September 2024, compared to a loss of Rs 141 million a year ago. Net sales rose 17.3% to Rs 22,418 million during the period as against Rs 19,114 million in July-September 2023.

For the year ended March 2024, PIRAMAL PHARMA reported 109.6% increase in net profit to Rs 178 million compared to net loss of Rs 1,865 million during FY23. Revenue of the company grew 15.4% to Rs 81,712 million during FY24.

The current Price to earnings ratio of PIRAMAL PHARMA, based on rolling 12 month earnings, stands at -1745.1.


Equitymaster requests your view! Post a comment on "PIRAMAL PHARMA Gains 6%; BSE HEALTHCARE Index Up 1.4%". Click here!